Expression and regulation of cytochrome P450 17 alpha-hydroxylase messenger ribonucleic acid levels and androstenedione production in hen granulosa cells.
Studies were conducted to evaluate the expression and regulation of cytochrome P450 17 alpha-hydroxylase (P450 17 alpha-OH) mRNA levels and androstenedione production in 6-8-mm-diameter follicle granulosa cells from the domestic hen. Although P450 17 alpha-OH mRNA was detected within granulosa cells from follicles at all stages of development (3-12-mm and preovulatory follicles), 8-12-fold higher levels were found in small, less developed follicles (3-12 mm in diameter) compared to the three largest follicles within the preovulatory hierarchy (F3 to F1 follicles). By comparison, P450 17 alpha-OH mRNA levels were 25-89-fold higher in theca tissue compared to the granulosa layer at comparable stages of development. Despite detection of P450 17 alpha-OH mRNA in granulosa cells from 6-8-mm follicles, androstenedione production was low to nondetectable when cells were cultured in the presence of exogenous progesterone (10 ng/ml). Treatment with FSH increased levels of P450 17 alpha-OH mRNA (by 6-fold after 16 h of treatment) and induced androstenedione production in cultured granulosa cells; these actions were mimicked by the cAMP analog, 8-bromo-cAMP. By contrast, addition of the growth factors transforming growth factor alpha (TGF alpha), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF) completely suppressed the stimulatory effects of FSH on both mRNA levels and androstenedione production, while insulin-like growth factor I (IGF-I) inhibited only androstenedione production. We conclude that in the granulosa layer of developing (< or = 12 mm) hen follicles the expression of P450 17 alpha-OH mRNA does not directly reflect P450 17 alpha-OH enzyme activity. Moreover, P450 17 alpha-OH mRNA levels dramatically decrease in granulosa cells from preovulatory (compared to developing) follicles, and in the theca layer from the F1 preovulatory follicle (compared to remaining follicles). It is proposed that FSH initiates P450 17 alpha-OH enzyme activity (and perhaps to a lesser extent regulates mRNA levels) at the time a follicle is recruited into the preovulatory hierarchy, and that this action is mediated, at least in part, by the adenylyl cyclase/cAMP second messenger pathway. On the other hand, growth factors (including TGF alpha, EGF, bFGF, and possibly IGF-I) may act to prevent premature expression of P450 17 alpha-OH activity in the granulosa layer of follicles that have yet to enter the rapid growth phase of follicle development.
Li
Z
Z
Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick 08903.
Johnson
A L
AL
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000735:Androstenedione / Q000096:biosynthesis*; D000818:Animals; D002478:Cells, Cultured; D002645:Chickens / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism*; D006080:Ovarian Follicle / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism*; D011994:Recombinant Proteins; D015290:Second Messenger Systems; D013254:Steroid 17-alpha-Hydroxylase / Q000235:genetics*; D013799:Theca Cells / Q000378:metabolism; D016211:Transforming Growth Factor alpha / Q000494:pharmacology
D012333:RNA, Messenger; D011994:Recombinant Proteins; D016211:Transforming Growth Factor alpha; D016222:Fibroblast Growth Factor 2; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000735:Androstenedione; D011374:Progesterone; D004815:Epidermal Growth Factor; D005640:Follicle Stimulating Hormone; D013254:Steroid 17-alpha-Hydroxylase